Did you know?
ChinaBio® Group is an investment, consulting and media firm helping western life science companies achieve success in China. ChinaBio works with U.S., European and APAC companies seeking partnerships, acquisitions, novel technologies and funding in China.  

>> Learn more…

Site Search

>> Advanced Search

  Quick Search:

Free Newsletter

  Email address:

Tiens Biotech Says 2008 Revenues Climbed 41%

publication date: Mar 31, 2009
View a Printer Friendly version of this page, allowing you to print the page. Send a summary of this page to someone via email.

Tiens Biotech Group reported that 2008 revenues rose 41% to $77.2 million. Net income was up 54% to $27.7 million or 39 cents per share, up from 25 cents per share in 2007. Tiens said its revenues were helped when Tianshi Engineering, a related company that sells Tiens’ products in China, announced in October that it would raise prices. The announcement caused customers to buy Tiens’ nutritional supplements and personal care products before the price increase. More details...

Stock Symbol: (NYSE AlternextUS: TBV)

Sorry... this feature or article is only available to subscribers.

>> Learn more about our subscription plans...

>> Free email newsletter...

>> Login...